logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Megamedical Ophthalmology-B (06622.HK) spent 340,100 Hong Kong dollars to repurchase 136,000 shares on June 25th.

date
26/06/2026
The Zhaoke Ophthalmology-B (06622.HK) announced on the Zhixin Finance and Economics APP that it repurchased 136,000 shares at a cost of 340,100 Hong Kong dollars on June 25, 2026.
Latest
1 m ago
Comlan Electronics: Some AI server power customers are involved in liquid cooling technology. The company collaborates with customers to develop liquid cooling projects.
3 m ago
Chinese Academy of Biological Sciences reaches strategic cooperation with Boruice Biotechnology
3 m ago
According to media reports, the South Korean Ministry of Labor has searched the office premises of Pohang Engineering and Construction Company regarding a worker's death incident.
5 m ago
Cao Cao partners with K2 Group and May Mobility to accelerate the overseas deployment of Robotaxi.
5 m ago
Yifan Communications has established a new precision technology company in Jiangxi.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.